185 related articles for article (PubMed ID: 34255531)
1. Do Macrocyclic Peptide Drugs Interact with Bile Salts under Simulated Gastrointestinal Conditions?
Dening TJ; Douglas JT; Hageman MJ
Mol Pharm; 2021 Aug; 18(8):3086-3098. PubMed ID: 34255531
[TBL] [Abstract][Full Text] [Related]
2. Human intestinal fluid factors affecting intestinal drug permeation in vitro.
Riethorst D; Brouwers J; Motmans J; Augustijns P
Eur J Pharm Sci; 2018 Aug; 121():338-346. PubMed ID: 29902511
[TBL] [Abstract][Full Text] [Related]
3. Bile Salt Micelles and Phospholipid Vesicles Present in Simulated and Human Intestinal Fluids: Structural Analysis by Flow Field-Flow Fractionation/Multiangle Laser Light Scattering.
Elvang PA; Hinna AH; Brouwers J; Hens B; Augustijns P; Brandl M
J Pharm Sci; 2016 Sep; 105(9):2832-2839. PubMed ID: 27103012
[TBL] [Abstract][Full Text] [Related]
4. Impact of Gut Microbiota-Mediated Bile Acid Metabolism on the Solubilization Capacity of Bile Salt Micelles and Drug Solubility.
Enright EF; Joyce SA; Gahan CG; Griffin BT
Mol Pharm; 2017 Apr; 14(4):1251-1263. PubMed ID: 28186768
[TBL] [Abstract][Full Text] [Related]
5. Investigation of solubilising effects of bile salts on an active pharmaceutical ingredient with unusual pH dependent solubility by NMR spectroscopy.
Vogtherr M; Marx A; Mieden AC; Saal C
Eur J Pharm Biopharm; 2015 May; 92():32-41. PubMed ID: 25720817
[TBL] [Abstract][Full Text] [Related]
6. Impact of phospholipid digests and bile acid pool variations on the crystallization of atazanavir from supersaturated solutions.
Enright EF; Joyce SA; Gahan CGM; Taylor LS
Eur J Pharm Biopharm; 2020 Aug; 153():68-83. PubMed ID: 32473291
[TBL] [Abstract][Full Text] [Related]
7. Statistical investigation of simulated fed intestinal media composition on the equilibrium solubility of oral drugs.
Zhou Z; Dunn C; Khadra I; Wilson CG; Halbert GW
Eur J Pharm Sci; 2017 Mar; 99():95-104. PubMed ID: 27940083
[TBL] [Abstract][Full Text] [Related]
8. Fasted and fed state human duodenal fluids: Characterization, drug solubility, and comparison to simulated fluids and with human bioavailability.
Dahlgren D; Venczel M; Ridoux JP; Skjöld C; Müllertz A; Holm R; Augustijns P; Hellström PM; Lennernäs H
Eur J Pharm Biopharm; 2021 Jun; 163():240-251. PubMed ID: 33872761
[TBL] [Abstract][Full Text] [Related]
9. Mimicking regional and fasted/fed state conditions in the intestine with the mucus-PVPA in vitro model: The impact of pH and simulated intestinal fluids on drug permeability.
Falavigna M; Klitgaard M; Steene E; Flaten GE
Eur J Pharm Sci; 2019 Apr; 132():44-54. PubMed ID: 30822502
[TBL] [Abstract][Full Text] [Related]
10. Canine intestinal contents vs. simulated media for the assessment of solubility of two weak bases in the human small intestinal contents.
Kalantzi L; Persson E; Polentarutti B; Abrahamsson B; Goumas K; Dressman JB; Reppas C
Pharm Res; 2006 Jun; 23(6):1373-81. PubMed ID: 16715357
[TBL] [Abstract][Full Text] [Related]
11. Investigating the effects of amphipathic gastrointestinal compounds on the solution behaviour of salt and free base forms of clofazimine: An in vitro evaluation.
Bannigan P; Stokes K; Kumar A; Madden C; Hudson SP
Int J Pharm; 2018 Dec; 552(1-2):180-192. PubMed ID: 30236646
[TBL] [Abstract][Full Text] [Related]
12. Mixed Micelles Loaded with Bile Salt: An Approach to Enhance Intestinal Transport of the BCS Class III Drug Cefotaxime in Rats.
Arafat M; Kirchhoefer C; Mikov M
Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):635-645. PubMed ID: 27686853
[TBL] [Abstract][Full Text] [Related]
13. Permeation enhancement of octreotide by specific bile salts in rats and human subjects: in vitro, in vivo correlations.
Fricker G; Fahr A; Beglinger C; Kissel T; Reiter G; Drewe J
Br J Pharmacol; 1996 Jan; 117(1):217-23. PubMed ID: 8825366
[TBL] [Abstract][Full Text] [Related]
14. Use of simulated intestinal fluids with Caco-2 cells and rat ileum.
Patel N; Forbes B; Eskola S; Murray J
Drug Dev Ind Pharm; 2006 Feb; 32(2):151-61. PubMed ID: 16537196
[TBL] [Abstract][Full Text] [Related]
15. Liposome formation from bile salt-lipid micelles in the digestion and drug delivery model FaSSIF(mod) estimated by combined time-resolved neutron and dynamic light scattering.
Nawroth T; Buch P; Buch K; Langguth P; Schweins R
Mol Pharm; 2011 Dec; 8(6):2162-72. PubMed ID: 21988605
[TBL] [Abstract][Full Text] [Related]
16. Effect of Surfactant-Bile Interactions on the Solubility of Hydrophobic Drugs in Biorelevant Dissolution Media.
Vinarov Z; Katev V; Burdzhiev N; Tcholakova S; Denkov N
Mol Pharm; 2018 Dec; 15(12):5741-5753. PubMed ID: 30351956
[TBL] [Abstract][Full Text] [Related]
17. Probing the molecular interactions between pharmaceutical polymeric carriers and bile salts in simulated gastrointestinal fluids using NMR spectroscopy.
Pigliacelli C; Belton P; Wilde P; Qi S
J Colloid Interface Sci; 2019 Sep; 551():147-154. PubMed ID: 31075629
[TBL] [Abstract][Full Text] [Related]
18. Statistical investigation of the full concentration range of fasted and fed simulated intestinal fluid on the equilibrium solubility of oral drugs.
Perrier J; Zhou Z; Dunn C; Khadra I; Wilson CG; Halbert G
Eur J Pharm Sci; 2018 Jan; 111():247-256. PubMed ID: 28987539
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of fasted and fed state simulated and human intestinal fluids as solvent system in the Ussing chambers model to explore food effects on intestinal permeability.
Wuyts B; Riethorst D; Brouwers J; Tack J; Annaert P; Augustijns P
Int J Pharm; 2015 Jan; 478(2):736-44. PubMed ID: 25510602
[TBL] [Abstract][Full Text] [Related]
20. Excluded volume effect of rat intestinal mucin on taurocholate/phosphatidylcholine mixed micelles.
Wiedmann TS; Liang W; Herrington H
J Colloid Interface Sci; 2004 Feb; 270(2):321-8. PubMed ID: 14697697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
